Member Info for Magsy18

If UKOG to gets through this period, it will be at the cost of shareholders who will be diluted into oblivion. There is £2m of the loan outstanding which would be an additional billion shares at the current price. The share price is this low for a reason and the argument that’s the share price is really, really low so it must go up from here is not particularly strong.

The share price has done nothing but drop for years. There has been nothing but dilution after dilution. Why, at a period of time when the world is in a major crisis, are things going to get better here?

Even without the placing I find it hard to believe it would have held over £3. All of the other covid shares drifted downwards with no news and there has been no GDR news related to anything except the placing.

I wouldn’t be surprised if people confused that news with something related to covid. The share price of these small cap pharma companies is being driven by speculation/sentiment related to covid at the moment.

Would love to be proved wrong but I can’t see this heading over £3 next week unless a huge order is secured.

They have sold £90m worth of their test and we have sold nothing.

When NCYT launched their test, using their market cap as a reference and taking the recent placing shares into account that would give us a share price of £2.50. It wasn’t until they announced approx £20m of sales that it headed upwards again to a market cap that would give a share price here of £3.10.

They were one of the first to the market and there has since been an increasing amount of competition and a decrease in the level of hype/sentiment. Are people expecting 10’s of millions in sales next week? If not, why would this match or exceed NCYT’s share price performance?

You posted a message titled ‘Post Facts not Rubbish‘ in AVCT. Perhaps you should take your own advice?

Also your closing price ramp of £2-£3 in AVCT on Friday didn’t quite happen?

There’s plenty of juicy stuff that’s been posted, your meaningless ramps aren’t needed.

I wonder if the timing of the CEO’s post here on Friday was just a coincidence...

It’s still a high risk investment so as long as you are comfortable with the idea that you could lose a large proportion of your investment then that’s a good start.

No one on here knows what to expect.

Without reading into this too much, it would take a very brave CEO to put themselves out there in public if he wasn’t almost certain that positive things were coming.

The Budd-Meister general himself! I think that we are all excited by the fact that these buds may flower into something quite spectacular. There are a lot of budding investors here and although people were annoyed at the placing, I think it’s safe to say you have made some buddies here. Anyway, I am off to feed my budgie and a nice cold bottle of beer. The brand.......? Estrella, sadly they were all out of bud.

Embarrassingly, two people upvoted that too.

Ghia, most genuine LTH have probably at least 4 bagged here. Cut them some slack.

That’s a gross oversimplification and a poor justification for an investment. It’s up there with comparing the share price of two companies without taking the number of shares into account.

Will PE multiples be realised though? Look at NCYT, comparatively they are much further along and have a good amount of revenue so far. In terms of PE this is not being reflected in NCYT so why would it be here?

Investing in this company is still high risk, high reward, for me. The concerns I have are two fold: -

Firstly, I think sentiment and hype around the covid opportunity has exaggerated/accelerated the gains in some of these pharma’s. This hype looks to me to have started to disappear which does impact the reward side a bit for me.

Secondly, how much of the market will be left when GDR get there and how much will the increasing competition impact profitability.

I still believe there are decent gains to be made here but don’t see anything dramatically changing in the short term. Hopefully I am wrong.

Selling your shares in order to ‘help the company’ doesn’t sound like behaviour that should be rewarded.

Which is why companies don’t do this very often. Be grateful you had the opportunity at all.

On 6th May you said..

“£3.50- £4 target
Not selling until we reach £3.50+”

This was after the placing news. It calls into question your integrity as an individual no?

The price at the time wasn’t 220, it was 230 as that is what you are offered. Google doesn’t report you the ‘price’.

Deod you said pretty much the same in March so presumably anything you say about takeovers should be disregarded?